Hjem › Uveal melanom › Californien
Uveal melanom kliniske forsøg i Californien
7 studier for Uveal melanom søger deltagere på steder i Californien.
Byer i Californien
Officiel studietekst (engelsk)
Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma
- UCLA Medical Center, Los Angeles
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT07804186Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
- UCLA Medical Center, Los Angeles
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 8. jun. 2026 · NCT03947385ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- Stanford Cancer Institute, Stanford
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 13. maj 2026 · NCT03686124Neoadjuvant Darovasertib in Primary Uveal Melanoma
- UCSD Moores Cancer Center, La Jolla
- Jules Stein Eye Institute, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
- og 4 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 6. maj 2026 · NCT07015190A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- UC San Diego Moores Cancer Center, La Jolla
- The Angeles Clinic and Research Institute, Los Angeles
- University of California Los Angeles, Los Angeles
- og 1 flere
RekruttererFase 2/3
Alle aldre · Alle køn · Opdateret 2. apr. 2026 · NCT06581406Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
- City of Hope, Duarte
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
- Stanford Cancer Institute, Stanford
RekruttererFase 1
Alder 18 til 75 · Alle køn · Opdateret 17. mar. 2026 · NCT04119024Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
- The Angeles Clinic and Research Institute, Los Angeles
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 4. dec. 2025 · NCT06121180Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.